Stryker Corp
Research Stryker Corp (SYK) on Bullrun: valuation model: 1.5% overvalued, market cap USD 106.38B, P/E 28.7, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSYK
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal1.5% overvalued
- Market capUSD 106.38B
- P/E28.7
- Dividend yield1.3%
- Financial periodQ2 2026
- RevenueUSD 6.59B
- Net incomeUSD 1.28B
- Free cash flowUSD 1.06B
- Gross margin68.3%
Valuation Snapshot
Bullrun's latest valuation model marks Stryker Corp as 1.5% overvalued; latest market cap is USD 106.38B; P/E is 28.7; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 28.73x versus a Healthcare sector median of 24.61x (16.8% above).
Latest dividend yield is 1.25% versus a Healthcare sector median of 1.84% (32.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 25.12B | USD 3.25B | USD 4.28B | 64.0% | 8.4 | USD 4.01B | USD 15.86B | USD 22.42B |
| FY2024 | USD 22.60B | USD 2.99B | USD 3.49B | 63.9% | 7.76 | USD 3.65B | USD 13.60B | USD 20.63B |
| FY2023 | USD 20.50B | USD 3.17B | USD 3.14B | 63.7% | 8.25 | USD 2.97B | USD 13.00B | USD 18.59B |
| FY2022 | USD 18.45B | USD 2.36B | USD 2.04B | 62.8% | 6.17 | USD 1.84B | USD 13.05B | USD 16.62B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 106.38B | 28.7 | 1.3% | 3.52 |
| 2025 | 2025-12-31 | USD 134.44B | 41.8 | 1.0% | 3.4 |
| 2024 | 2024-12-31 | USD 137.32B | 46.4 | 0.9% | 3.24 |
| 2023 | 2023-12-29 | USD 113.78B | 44.4 | 1.0% | 3.05 |
| 2022 | 2022-12-30 | USD 92.52B | 38.0 | 1.2% | 2.85 |
| 2021 | 2021-12-31 | USD 100.95B | 51.3 | 1.0% | 2.59 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.52 USD, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3.4 USD |
| FY2024 | 3.24 USD |
| FY2023 | 3.05 USD |
| FY2022 | 2.85 USD |
About Stryker Corp
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
ETFs that hold Stryker Corp
Stryker Corp is one of the ten largest holdings of 5 ETFs that investors in Europe can buy, most traded first:
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Stryker Corp overvalued or undervalued?
Bullrun's valuation model currently marks Stryker Corp as 1.5% overvalued.
What is Stryker Corp's market cap?
Stryker Corp's market capitalization is USD 106.38B.
What is Stryker Corp's P/E ratio?
Stryker Corp's price-to-earnings (P/E) ratio is 28.7.
Does Stryker Corp pay a dividend?
Stryker Corp has a dividend yield of 1.3%.
What does Stryker Corp do?
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.